All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @thealigilbert on TikTok · 49s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @thealigilbert's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00What is the best protocol for the average guy to optimize TRT?
  2. 0:03The most optimal injection protocol would be daily intramuscular injections,
  3. 0:07but that doesn't have sustainability long term.
  4. 0:10Once the novelty wears off, you're not going to do it.
  5. 0:12People are like, how do I really do this the best possible way?
  6. 0:14I think that's the sweet spot between sustainability and optimal stability.
  7. 0:19When it comes to cream, I think the HRT-based cream is by far superior.
  8. 0:23The HRT one is best, both in terms of the levels that we see in practice.
  9. 0:28It absorbs the quickest so you don't have to stand there with your ball sack out,
  10. 0:31just scrolling Instagram or something, waiting for it to dry.
  11. 0:34It absorbs very quickly, it gets into the body very well,
  12. 0:37and if people really want to optimize that, can you do it once a day?
  13. 0:40But twice a day is going to give you the stability,
  14. 0:42and when we look at the outcomes clinically,
  15. 0:45stability tends to lead to greater resolution of negative symptoms.

TRT optimization protocols: what the evidence actually supports

Ali Gilbert

TikTok creator

43.2K viewsWatch on TikTok

Quick answer

Testosterone replacement therapy protocols vary significantly in their pharmacokinetic profiles, with injection frequency and route of administration both affecting serum testosterone stability. The creator advocates for twice-daily compounded transdermal testosterone cream as a balance between compliance and hormonal stability, a claim with some pharmacokinetic support but limited comparative trial evidence against other approved topical formulations. Symptom resolution on TRT depends on multiple variables beyond dosing stability, including estradiol balance, SHBG levels, and patient-specific metabolic factors.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For TRT optimization protocols: what the evidence actually supports, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

TRT optimization protocols: what the evidence actually supports should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "TRT optimization protocols: what the evidence actually supports" from Ali Gilbert. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Testosterone replacement therapy protocols vary significantly in their pharmacokinetic profiles, with injection frequency and route of administration both affecting serum testosterone stability.

The reason this review is not generic is the source wording and the canonical claim label "trt what is the best protocol for the average guy to optimize tr." In this clip, the useful excerpt is: "What is the best protocol for the average guy to optimize TRT?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Twice-daily topical testosterone application has a rational basis for improving stability compared to once-daily, but direct comparative symptom data between dosing frequencies is limited.
People who land here are usually trying to understand whether the Testosterone claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Testosterone replacement therapy protocols vary significantly in their pharmacokinetic profiles, with injection frequency and route of administration both affecting serum testosterone stability.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Testosterone replacement therapy protocols vary significantly in their pharmacokinetic profiles, with injection frequency and route of administration both affecting serum testosterone stability. The creator advocates for twice-daily compounded transdermal testosterone cream as a balance between compliance and hormonal stability, a claim with some pharmacokinetic support but limited comparative trial evidence against other approved topical formulations. Symptom resolution on TRT depends on multiple variables beyond dosing stability, including estradiol balance, SHBG levels, and patient-specific metabolic factors.
  • More frequent testosterone dosing, whether injections or topical, reduces peak-to-trough serum fluctuation. This is pharmacokinetically established, not just clinical opinion.
  • Twice-daily topical testosterone application has a rational basis for improving stability compared to once-daily, but direct comparative symptom data between dosing frequencies is limited.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • More frequent testosterone dosing, whether injections or topical, reduces peak-to-trough serum fluctuation. This is pharmacokinetically established, not just clinical opinion.
  • Twice-daily topical testosterone application has a rational basis for improving stability compared to once-daily, but direct comparative symptom data between dosing frequencies is limited.
  • Scrotal application of transdermal testosterone increases DHT conversion significantly compared to other body sites. This is a clinically relevant variable that the video does not address.
  • No peer-reviewed trial has established that any single compounded cream formulation is superior to FDA-approved topical testosterone products in absorption or outcomes.
  • Bhasin et al. (2021, NEJM) identified long-term adherence as one of the strongest predictors of TRT outcomes, supporting the creator's practical argument about sustainability.
  • Symptom resolution on TRT depends on testosterone stability, estradiol balance, SHBG levels, and metabolic health. Attributing outcomes to dosing schedule alone is an oversimplification.
  • Every-other-day or twice-weekly subcutaneous injections offer a middle ground between daily IM injections and topical cream that the video does not discuss.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @thealigilbert actually say?

The video argues that daily intramuscular injections are theoretically the most optimal TRT protocol but fail in practice because compliance drops off. The real sweet spot, according to the creator, is a compounded HRT-based testosterone cream applied twice daily. The claim is that this cream "absorbs the quickest," gets into the body efficiently, and that twice-daily dosing produces hormonal stability that leads to "greater resolution of negative symptoms."

These are specific, testable claims, not just vibes. The creator is essentially arguing that a twice-daily topical protocol outperforms injections on a practical and clinical basis for most men. That deserves a closer look.

Does the science back this up?

Partially, but the picture is messier than the video lets on. The injection frequency argument has decent support. Daily subcutaneous injections do produce the most stable testosterone levels, but the compliance problem the creator names is real. A 2020 review by Khera et al. in Sexual Medicine Reviews acknowledged that injection frequency affects tolerability and long-term adherence.

On topical testosterone, the pharmacokinetics are genuinely different from injections. Transdermal testosterone avoids the sharp peaks and troughs associated with weekly intramuscular injections. A 2014 study by Wang et al. in the Journal of Clinical Endocrinology and Metabolism confirmed that transdermal delivery produces more consistent serum levels compared to less-frequent injections. Twice-daily application does logically extend that stability further, and there is clinical rationale behind it.

However, the specific claim about one compounded cream formulation being "by far superior" to other topical options is not something a single TikTok video can establish. Absorption varies significantly by vehicle, body site, and individual skin characteristics.

What did they get wrong (or right)?

They got the injection frequency vs. stability trade-off broadly right. The evidence does support the idea that more frequent dosing, whether injections or topical, reduces serum testosterone fluctuation. That part is not controversial.

Where the video oversells is the claim that one specific compounded cream is "by far superior." There is no peer-reviewed head-to-head trial comparing proprietary compounded HRT cream formulations against FDA-approved topical gels like AndroGel or Testim on absorption speed and symptom resolution. The "absorbs the quickest" claim is anecdotal and practice-based, not study-based. Clinical observation is data, but it is not the same as controlled evidence.

The creator also implies that stability directly causes "greater resolution of negative symptoms." Symptom resolution on TRT is multifactorial. Estradiol management, SHBG levels, sleep quality, and baseline health all contribute. Attributing outcomes primarily to dosing stability is an oversimplification, even if stability is a meaningful variable.

  • Injection frequency affecting stability: supported by evidence
  • Topical twice-daily dosing for stability: reasonable clinical rationale
  • Specific cream brand being "by far superior": not established by published data
  • Stability alone driving symptom resolution: overstated

What should you actually know?

For most men on TRT, the best protocol is the one they will actually follow consistently. The creator is right that theoretical optimality means nothing if you quit after six weeks. A 2021 paper by Bhasin et al. in the New England Journal of Medicine reinforced that adherence is one of the strongest predictors of treatment outcomes in testosterone therapy.

Twice-daily topical testosterone has real pharmacokinetic advantages over once-weekly intramuscular injections. But twice-weekly or every-other-day subcutaneous injections with a smaller needle also produce reasonably stable levels and are easier to sustain than daily IM injections. The binary framing of "injections vs. cream" skips over that middle ground.

One important safety note: compounded testosterone creams applied to scrotal skin show dramatically higher absorption than application to other body sites. DHT conversion is also elevated with scrotal application. These are not minor variables. Anyone considering topical testosterone should have that conversation with a licensed provider, not base their protocol on a TikTok video, however well-informed the creator may be.

Bottom line: is this worth your time?

The video is more informed than most TRT content on TikTok. The creator is not selling snake oil, and the core argument about stability mattering for symptom resolution is defensible. But "by far superior" is doing a lot of work for a claim that rests on clinical observation rather than comparative trials. Take the framework, skip the brand loyalty, and run any protocol changes past an actual provider who can order labs.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Ali Gilbert · TikTok creator

43.2K views on this video

What Is The Best Protocol For The Average Guy To Optimize TRT?

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about more frequent testosterone dosing, whether injections?

More frequent testosterone dosing, whether injections or topical, reduces peak-to-trough serum fluctuation. This is pharmacokinetically established, not just clinical opinion.

What does the video say about twice-daily topical testosterone application has a rational basis for improving?

Twice-daily topical testosterone application has a rational basis for improving stability compared to once-daily, but direct comparative symptom data between dosing frequencies is limited.

What does the video say about scrotal application of transdermal testosterone increases dht conversion significantly compared?

Scrotal application of transdermal testosterone increases DHT conversion significantly compared to other body sites. This is a clinically relevant variable that the video does not address.

What does the video say about no peer-reviewed trial has established?

No peer-reviewed trial has established that any single compounded cream formulation is superior to FDA-approved topical testosterone products in absorption or outcomes.

What does the video say about bhasin et al. (2021, nejm) identified long-term adherence as one?

Bhasin et al. (2021, NEJM) identified long-term adherence as one of the strongest predictors of TRT outcomes, supporting the creator's practical argument about sustainability.

What does the video say about symptom resolution on trt depends on testosterone stability, estradiol balance,?

Symptom resolution on TRT depends on testosterone stability, estradiol balance, SHBG levels, and metabolic health. Attributing outcomes to dosing schedule alone is an oversimplification.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Ali Gilbert, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.